Research has revealed a significant correlation of FASN expression with the degree of steatosis in primary human hepatocytes in vitro as well as in experimental murine models and in the livers of patients with NAFLD in vivo [62]. The gene discussed is FASN; the disease is metabolic dysfunction-associated steatotic liver disease.